what products does pharmaceuticals make

SMS Pharmaceuticals Limited manufactures and sells Active Pharmaceutical Ingredients (APIs) and intermediates, including anti-retroviral, anti-inflammatory, anti-viral, anti-diabetic, anti-fungal, anti-epileptic, and other specialty pharmaceutical products for both domestic and international markets.

what does pharmaceuticals do

SMS Pharmaceuticals Limited is a diversified and integrated pharmaceutical company that designs, manufactures, and markets APIs and intermediates through its global operations, supported by research and state-of-the-art facilities.

what sector is pharmaceuticals in

SMS Pharmaceuticals Limited operates in the pharmaceutical sector, specifically focusing on the manufacturing and supply of Active Pharmaceutical Ingredients (APIs) and intermediates.

when was pharmaceuticals founded

SMS Pharmaceuticals Limited was founded in 1990, starting as a single facility-single product manufacturer and expanding to become a global API manufacturer.

who owns pharmaceuticals

SMS Pharmaceuticals Limited is owned by its shareholders, with the company being a publicly traded entity on the stock exchanges in India.

SMSPHARMA

NSEBSE

SMS Pharmaceuticals Limited

Healthcare· Pharmaceuticals & Biotechnology· INE812G01025· Scrip: 532815

EN हिन्दी ગુજરાતી मराठी

₹૪૦૬.૦૦

▼ 4.10 (-1.00%)

1/5/2026, 9:45:09 am

NSE

₹૪૦૬.૦૦

▼ ૪.૧૦

-૧.૦૦%

BSE

₹૪૦૪.૫૫

▲ ૫.૨૫

+૦.૦૦%

૨૪૪ ટ્રેડિંગ દિવસ · 1Y સમયગાળો

આજ 

ખૂલ્લ૪૧૪.૦૦

ઊંચ૪૧૪.૪૫

નીચ૩૯૭.૨૫

અગાઉ બંધ૪૧૦.૧૦

વૉલ્યુમ૯.૩૭Cr

મૂલ્ય₹૦.૩Cr

L: 397.25H: 414.45

52 સપ્તાહ

નીચ₹૨૦૭.૭૦

ઊંચ₹૪૪૭.૮૦

૮૩% 52 સપ્તાહ રેન્જમાં

માહિતી

અંકિત મૂલ્ય₹૧

સૂચિબદ્ધ2007-02-28

ISININE812G01025

SeriesB

BSE સ્ક્રિપ532815

મુખ્ય સૂચકો

1D

-1.00%

1W

-2.30%

1M

+2.75%

3M

+31.12%

6M

+38.55%

મૂલ્યાંકન

P/E (TTM)૫૧.૯૮

P/E (Qtr Ann.)૪૭.૨૧

P/Sales૪.૬૭

બજાર મૂડી₹3643 Cr

વૃદ્ધિ (ત્રિ.)

આવક-11.89%

PAT+29.38%

EPS+27.22%

નફાકારકતા

EBITDA માર્જિન૧૮.૦%

ચોખ્ખો માર્જિન૧૦.૫%

TTM EBITDA M.૧૫.૩%

TTM ચોખ્ખો M.૮.૪%

ડિવિડન્ડ

યીલ્ડ૦.૧૦%

છેલ્લો DPS₹૦.૪

ચૂકવણી ગુણોત્તર૧૮.૬%

વૃદ્ધિ+0.00%

TTM આવક

₹780 Cr

TTM EBITDA

₹119 Cr

TTM PAT

₹66 Cr

TTM EPS

₹૭.૮૧

પ્રતિ શેર આવક

₹૮૩.૩

ત્રિમાસિક નાણાકીય

આવક

EBITDA

PAT

EPS

ત્રિમાસ	આવક	Expenses	EBITDA	PBT	PAT	EPS
2024-12-31	173 Cr	153 Cr	31 Cr	22 Cr	18 Cr	₹2.15
2024-09-30	197 Cr	179 Cr	28 Cr	20 Cr	14 Cr	₹1.69
2024-06-30	164 Cr	144 Cr	30 Cr	22 Cr	16 Cr	₹1.93
2024-03-31	246 Cr	226 Cr	30 Cr	22 Cr	17 Cr	₹2.04
2023-12-31	161 Cr	146 Cr	25 Cr	17 Cr	11 Cr	₹1.36
2023-09-30	167 Cr	152 Cr	23 Cr	15 Cr	12 Cr	₹1.39
2023-03-31	149 Cr	140 Cr	19 Cr	11 Cr	6 Cr	₹0.73
2022-12-31	149 Cr	144 Cr	15 Cr	7 Cr	4 Cr	₹0.44

શેરહોલ્ડિંગ પેટર્ન

વર્તમાન — 2026-03-31

પ્રમોટર68.1%

FII0.3%

DII3.0%

સાર્વજનિક31.9%

પ્રમોટર હોલ્ડિંગ ટ્રેન્ડ

કોર્પોરેટ ક્રિયાઓ

એક્સ-તારીખ	પ્રકાર	હેતુ
2025-09-22	Dividend	Dividend - Re 0.40 Per Share
2024-09-23	Other	Annual General Meeting
2024-09-23	Dividend	Dividend - Rs 0.40 Per Share
2023-09-22	Dividend	Dividend - Re 0.30 Per Share
2023-09-22	Other	Annual General Meeting
2022-09-22	Other	Annual General Meeting
2022-09-22	Dividend	Dividend - Re 0.30 Per Share
2021-09-22	Dividend	Annual General Meeting/ Dividend Rs 0.30 Per Share
2020-09-17	Other	Annual General Meeting
2020-03-26	Dividend	Interim Dividend - Rs 0.25 Per Share
2019-09-19	Dividend	Dividend - Rs 0.25 Per Share
2018-09-11	Dividend	Annual General Meeting/Dividend Re 0.25 Per Share
2017-09-20	Dividend	Annual General Meeting/Dividend - Rs 0.20 Per Share
2017-06-22	Other	Scheme Of Arrangement
2016-09-22	Dividend	Dividend Re 0.20 Per Share
2015-12-17	Split	Face Value Split (Sub-Division) - From Rs 10/- Per Share To Re 1/- Per Share
2015-09-22	Dividend	Annual General Meeting/ Dividend - Rs 2/- Per Share
2014-09-23	Dividend	Annual General Meeting And Dividend Rs.2/- Per Share
2013-09-23	Dividend	Annual General Meeting / Dividend - Rs 2 Per Share
2012-09-20	Other	Annual General Meeting

કમાણી ટ્રાન્સક્રિપ્ટ

SMS Pharmaceuticals Limited has informed the Exchange about Investor Presentation

10 Nov 2025NSE19K chars

Read →

SMS Pharmaceuticals Limited has informed the Exchange about Investor Presentation

10 Aug 2025NSE12K chars

Read →

SMS Pharmaceuticals Limited has informed the Exchange about Investor Presentation

31 May 2025NSE15K chars

Read →

SMS Pharmaceuticals Limited has informed the Exchange about Investor Presentation

12 Feb 2025NSE13K chars

Read →

SMS Pharmaceuticals Limited has informed the Exchange about Investor Presentation

9 Nov 2023NSE33K chars

Read →

SMS Pharmaceuticals Limited has informed the Exchange about Investor Presentation

9 Aug 2023NSE29K chars

Read →

SMS Pharmaceuticals Limited has informed the Exchange about Investor Presentation

25 May 2023NSE30K chars

Read →

SMS Pharmaceuticals Limited has informed the Exchange about Transcript of Analysts/Institutional Inv...

23 Nov 2022NSE44K chars

Read →

SMS Pharmaceuticals Limited has informed the Exchange about Investor Presentation

14 Nov 2022NSE32K chars

Read →

SMS Pharmaceuticals Limited has informed the Exchange about Transcript of Analysts/Institutional Inv...

23 Aug 2022NSE38K chars

Read →

SMS Pharmaceuticals Limited has informed the Exchange about Investor Presentation

13 Aug 2022NSE29K chars

Read →

SMS Pharmaceuticals Limited has informed the Exchange about Transcript of Analysts/Institutional Inv...

9 Jun 2022NSE44K chars

Read →

SMS Pharmaceuticals Limited has informed the Exchange about Investor Presentation

2 Jun 2022NSE30K chars

Read →

SMS Pharmaceuticals Limited has informed the Exchange regarding 'Re-schedule of Conference Call for ...

18 Feb 2022NSE1K chars

Read →

SMS Pharmaceuticals Limited has informed the Exchange regarding 'Intimation of conference call'.

11 Feb 2022NSE2K chars

Read →

SMS Pharmaceuticals Limited has informed the Exchange regarding 'Press release and investor presenta...

10 Feb 2022NSE39K chars

Read →

SMS Pharmaceuticals Limited has informed the Exchange regarding 'Earnings call Transcript Q2 FY22'.

23 Nov 2021NSE65K chars

Read →

SMS Pharmaceuticals Limited has informed the Exchange regarding 'Revised intimation of conference ca...

16 Nov 2021NSE2K chars

Read →

SMS Pharmaceuticals Limited has informed the Exchange regarding 'Intimation of Conference call Ref: ...

16 Nov 2021NSE2K chars

Read →

SMS Pharmaceuticals Limited has informed the Exchange regarding 'Intimation of conference callRef: R...

16 Nov 2021NSE2K chars

Read →

ભાવ ઇતિહાસ

તારીખ	ખૂલ્લ	ઊંચ	નીચ	બંધ	વૉલ્યુમ
2026-04-30	૪૧૪.૦૦	૪૧૪.૪૫	૩૯૭.૨૫	૪૦૩.૭૦	૨.૦૫L
2026-04-29	૩૯૨.૦૦	૪૧૫.૦૦	૩૯૧.૧૦	૪૧૦.૧૦	૪.૧૬L
2026-04-28	૩૯૯.૬૫	૪૦૩.૯૦	૩૮૭.૦૦	૩૯૦.૨૫	૨.૧૨L
2026-04-27	૩૯૭.૨૦	૪૦૫.૯૦	૩૯૫.૦૦	૩૯૯.૬૫	૧.૫૧L
2026-04-24	૪૧૮.૫૦	૪૧૯.૦૦	૩૯૨.૨૦	૩૯૬.૭૦	૩.૬૬L
2026-04-23	૪૨૦.૨૫	૪૩૨.૬૦	૪૧૩.૦૦	૪૧૫.૫૫	૪.૩૫L
2026-04-22	૪૦૫.૧૦	૪૨૩.૦૦	૪૦૫.૧૦	૪૨૦.૨૫	૧.૯૯L
2026-04-21	૪૨૩.૦૦	૪૨૪.૮૫	૪૦૭.૦૦	૪૦૮.૧૦	૨.૧૨L
2026-04-20	૪૨૮.૯૫	૪૩૩.૫૦	૪૧૫.૧૦	૪૧૭.૭૦	૧.૮૯L
2026-04-17	૪૨૫.૮૦	૪૩૪.૦૦	૪૨૫.૧૦	૪૨૯.૦૦	૧.૬૧L
2026-04-16	૪૩૯.૮૫	૪૪૬.૦૦	૪૨૧.૪૦	૪૨૪.૪૦	૪.૦૦L
2026-04-15	૪૨૫.૦૦	૪૪૭.૮૦	૪૨૪.૦૦	૪૩૮.૩૦	૬.૧૭L
2026-04-13	૪૧૦.૦૦	૪૨૨.૫૦	૩૯૭.૬૦	૪૧૬.૮૫	૨.૫૭L
2026-04-10	૪૨૦.૦૦	૪૨૯.૯૫	૪૧૪.૧૦	૪૧૮.૪૦	૪.૧૫L
2026-04-09	૪૦૦.૦૦	૪૧૯.૯૦	૩૯૫.૩૦	૪૧૫.૦૦	૫.૧૧L
2026-04-08	૪૦૫.૯૦	૪૦૫.૯૦	૩૯૩.૧૦	૩૯૯.૨૦	૨.૧૭L
2026-04-07	૩૮૬.૦૦	૩૯૬.૭૦	૩૮૩.૦૫	૩૯૦.૦૫	૨.૧૪L
2026-04-02	૩૮૫.૦૦	૩૯૧.૧૫	૩૭૦.૨૫	૩૮૮.૨૫	૩.૮૪L
2026-04-01	૩૯૩.૮૦	૪૦૪.૯૦	૩૮૨.૦૫	૩૯૨.૭૫	૩.૩૫L
2026-03-27	૩૯૮.૯૫	૪૧૨.૦૫	૩૮૫.૦૦	૩૮૬.૧૫	૩.૩૭L
2026-03-25	૩૯૫.૫૦	૪૧૩.૮૦	૩૯૪.૦૦	૪૦૪.૫૫	૬.૫૩L
2026-03-24	૩૭૬.૬૫	૩૯૯.૬૦	૩૭૨.૬૦	૩૯૫.૧૫	૫.૨૨L
2026-03-20	૩૬૭.૨૫	૩૯૪.૨૫	૩૬૭.૨૫	૩૮૫.૦૫	૪.૯૨L
2026-03-19	૩૭૬.૫૫	૩૭૯.૦૦	૩૬૨.૬૦	૩૬૬.૧૦	૧.૭૨L
2026-03-18	૩૭૫.૧૦	૩૮૭.૨૦	૩૭૩.૯૦	૩૮૨.૨૫	૨.૨૪L
2026-03-17	૩૬૫.૮૦	૩૭૮.૮૦	૩૬૫.૮૦	૩૭૨.૭૦	૨.૧૭L
2026-03-16	૩૭૦.૦૦	૩૭૯.૯૦	૩૫૬.૨૦	૩૬૬.૧૫	૪.૨૩L
2026-03-13	૪૦૦.૦૦	૪૦૩.૦૦	૩૬૬.૨૫	૩૬૮.૭૫	૭.૫૮L
2026-03-12	૪૧૦.૦૦	૪૧૯.૯૦	૪૦૧.૧૦	૪૦૫.૨૦	૩.૮૦L
2026-03-11	૪૨૨.૦૦	૪૩૩.૯૦	૪૧૧.૦૫	૪૧૩.૪૦	૭.૭૪L

વારંવાર પૂછાતા પ્રશ્નો

વિશે

એસએમએસ ફાર્માસ્યુટિકલ્સ લિમિટેડ, 1987 માં સ્થાપિત અને હૈદરાબાદ, ભારતમાં મુખ્ય મથક, એક સંકલિત ફાર્માસ્યુટિકલ કંપની છે જે સક્રિય ફાર્માસ્યુટિકલ ઘટકો (API) અને એન્ટિ-અલ્સર, એન્ટિ-ફંગલ, એન્ટિ-આધાશીશી, એન્ટિ-વાયરલ, એન્ટિ-વાયરલ, એન્ટિ-વાયરલ અને એન્ટિ-વાયરલ જેવી ઉપચારાત્મક શ્રેણીઓમાં જટિલ મધ્યસ્થીઓમાં વિશેષતા ધરાવે છે. કંપની બહુવિધ ઉત્પાદન સુવિધાઓ અને સંશોધન કેન્દ્રો ચલાવે છે, 1,000 થી વધુ વ્યાવસાયિકોને રોજગારી આપે છે, અને 10 થી વધુ ઉપચારાત્મક ઉત્પાદનોમાં વૈશ્વિક નેતૃત્વની સ્થિતિ ધરાવે છે.

BOARD OF DIRECTORS

Vamsi Krishna Potluri

Whole-time Director

Shravan Kudaravalli

Independent Director

Srinivas Sarvepalli

Independent Director